Interleukin-17: friend or foe in atherosclerosis?

被引：46
|
作者：
Taleb, Soraya [2 ,3 ]
Tedgui, Alain [2 ,3 ]
Mallat, Ziad [1 ,2 ,3 ]
机构：
[1] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Cardiovasc Med, Cambridge CB2 2QQ, England
[2] INSERM, U970, Paris, France
[3] Paris Descartes Univ, Paris, France
来源：
CURRENT OPINION IN LIPIDOLOGY | 2010年 / 21卷 / 05期
关键词：
atherosclerosis; interleukin-17; lymphocytes; T(H)17 CELL-DIFFERENTIATION; ROR-GAMMA-T; EXPERIMENTAL AUTOIMMUNE UVEITIS; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; DEFICIENT MICE; MYOCARDIAL-INFARCTION; ASSOCIATION ANALYSIS; EFFECTOR RESPONSE; INTERFERON-GAMMA;
D O I：
10.1097/MOL.0b013e32833dc7f9
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
IL-17 seems to have a modulatory role in atherosclerosis. Future studies are needed to better determine the molecular mechanisms involved in this regulation and examine whether targeting IL-17 pathway will be useful to treat cardiovascular diseases.
引用
收藏
页码：404 / 408
页数：5
相关论文
共 50 条
  • [41] Aggravated Atherosclerosis and Vascular Inflammation With Reduced Kidney Function Depend on Interleukin-17 Receptor A and Are Normalized by Inhibition of Interleukin-17A
    Nordlohne, Johannes
    Helmke, Alexandra
    Ge, Shuwang
    Rong, Song
    Chen, Rongjun
    Waisman, Ari
    Haller, Hermann
    von Vietinghoff, Sibylle
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2018, 3 (01): : 54 - 66
  • [42] Interleukin-8 and Interleukin-17 for Cancer
    Zarogoulidis, Paul
    Katsikogianni, Fotini
    Tsiouda, Theodora
    Sakkas, Antonios
    Katsikogiannis, Nikolaos
    Zarogoulidis, Konstantinos
    CANCER INVESTIGATION, 2014, 32 (05) : 197 - 205
  • [43] 17β-estradiol in colorectal cancer: friend or foe?
    Wu, Zihong
    Xiao, Chong
    Wang, Jiamei
    Zhou, Min
    You, Fengming
    Li, Xueke
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [44] NF-κB activation in atherosclerosis:: a friend or a foe?
    Mallat, Z
    Tedgui, A
    BLOOD, 2004, 103 (03) : 754 - 755
  • [45] Endothelial-to-Mesenchymal Transition in Atherosclerosis: Friend or Foe?
    Gole, Sarin
    Tkachenko, Svyatoslav
    Masannat, Tarek
    Baylis, Richard A.
    Cherepanova, Olga A.
    CELLS, 2022, 11 (19)
  • [46] Lecithin: cholesterol acyltransferase: old friend or foe in atherosclerosis?
    Kunnen, Sandra
    Van Eck, Miranda
    JOURNAL OF LIPID RESEARCH, 2012, 53 (09) : 1783 - 1799
  • [47] Interleukin-17 Links Inflammatory Cross-Talks Between Comorbid Psoriasis and Atherosclerosis
    Wang, Yan
    Zang, Jinxin
    Liu, Chen
    Yan, Zhongrui
    Shi, Dongmei
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [48] Interleukin-18 in Intestinal Inflammation: Friend and Foe?
    Siegmund, Britta
    IMMUNITY, 2010, 32 (03) : 300 - 302
  • [49] Interleukin-6 and insulin sensitivity: friend or foe?
    Carey, AL
    Febbraio, MA
    DIABETOLOGIA, 2004, 47 (07) : 1135 - 1142
  • [50] Interleukin-21 in cancer immunotherapy Friend or foe?
    Stolfi, Carmine
    Pallone, Francesco
    Macdonald, Thomas T.
    Monteleone, Giovanni
    ONCOIMMUNOLOGY, 2012, 1 (03) : 351 - 354
12345